

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 7.32917095 |
| 2 | chemical homeostasis within a tissue (GO:0048875) | 5.80956438 |
| 3 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.60230206 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 4.86613118 |
| 5 | response to peptidoglycan (GO:0032494) | 4.83350136 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.81627506 |
| 7 | cysteine metabolic process (GO:0006534) | 4.70159487 |
| 8 | regulation of vitamin metabolic process (GO:0030656) | 4.69919885 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.62288985 |
| 10 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.61464152 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34644677 |
| 12 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.28405984 |
| 13 | urate metabolic process (GO:0046415) | 4.22620769 |
| 14 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.20944774 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.09138410 |
| 16 | regulation of fever generation (GO:0031620) | 4.05084712 |
| 17 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.04814899 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.98761780 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 3.98761780 |
| 20 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.96819142 |
| 21 | regulation of podosome assembly (GO:0071801) | 3.96082347 |
| 22 | lysine catabolic process (GO:0006554) | 3.95131246 |
| 23 | lysine metabolic process (GO:0006553) | 3.95131246 |
| 24 | transcytosis (GO:0045056) | 3.95011041 |
| 25 | positive regulation of heat generation (GO:0031652) | 3.91257189 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.86443485 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 3.85297143 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.85297143 |
| 29 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.82298867 |
| 30 | ethanol oxidation (GO:0006069) | 3.80624893 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.79575429 |
| 32 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.77974587 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.76290220 |
| 34 | drug transmembrane transport (GO:0006855) | 3.71908529 |
| 35 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.71771818 |
| 36 | valine metabolic process (GO:0006573) | 3.68835392 |
| 37 | regulation of chemokine biosynthetic process (GO:0045073) | 3.66669086 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.65940579 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.62697297 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.62697297 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.62697297 |
| 42 | regulation of endothelial cell differentiation (GO:0045601) | 3.61458516 |
| 43 | homocysteine metabolic process (GO:0050667) | 3.60158652 |
| 44 | sodium-independent organic anion transport (GO:0043252) | 3.59565504 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.57559788 |
| 46 | cellular response to zinc ion (GO:0071294) | 3.56070101 |
| 47 | regulation of macrophage chemotaxis (GO:0010758) | 3.54185075 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53463360 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.52597519 |
| 50 | protein carboxylation (GO:0018214) | 3.52597519 |
| 51 | regulation of protein activation cascade (GO:2000257) | 3.52244834 |
| 52 | monocyte chemotaxis (GO:0002548) | 3.50317750 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.48432810 |
| 54 | tryptophan metabolic process (GO:0006568) | 3.47443976 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.44894046 |
| 56 | regulation of complement activation (GO:0030449) | 3.43682566 |
| 57 | eosinophil chemotaxis (GO:0048245) | 3.43118527 |
| 58 | lymph vessel development (GO:0001945) | 3.42447940 |
| 59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.40455112 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39905352 |
| 61 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.39533487 |
| 62 | response to thyroid hormone (GO:0097066) | 3.39446565 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39079153 |
| 64 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.38287960 |
| 65 | urea metabolic process (GO:0019627) | 3.36728675 |
| 66 | urea cycle (GO:0000050) | 3.36728675 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35266153 |
| 68 | negative regulation of fibrinolysis (GO:0051918) | 3.35054098 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.32714835 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 3.32032391 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.29861899 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.29861899 |
| 73 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.29861899 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.29861899 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 3.29861899 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 3.29861899 |
| 77 | heme transport (GO:0015886) | 3.29321772 |
| 78 | cellular extravasation (GO:0045123) | 3.26709308 |
| 79 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.25519912 |
| 80 | regulation of chronic inflammatory response (GO:0002676) | 3.21746157 |
| 81 | glyoxylate metabolic process (GO:0046487) | 3.20755741 |
| 82 | regulation of vasculogenesis (GO:2001212) | 3.20388192 |
| 83 | pattern specification involved in kidney development (GO:0061004) | 3.20367491 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17626781 |
| 85 | reverse cholesterol transport (GO:0043691) | 3.16146361 |
| 86 | cellular response to ethanol (GO:0071361) | 3.14731311 |
| 87 | immunoglobulin mediated immune response (GO:0016064) | 3.13504814 |
| 88 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.12771380 |
| 89 | response to phenylpropanoid (GO:0080184) | 3.12416875 |
| 90 | glycosphingolipid catabolic process (GO:0046479) | 3.11257691 |
| 91 | hormone catabolic process (GO:0042447) | 3.11075339 |
| 92 | amino-acid betaine metabolic process (GO:0006577) | 3.10889521 |
| 93 | T-helper 1 type immune response (GO:0042088) | 3.09812268 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.08658409 |
| 95 | peptide catabolic process (GO:0043171) | 3.08615852 |
| 96 | phosphate ion transmembrane transport (GO:0035435) | 3.08459507 |
| 97 | drug transport (GO:0015893) | 3.07709298 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 3.06098893 |
| 99 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.05660854 |
| 100 | eosinophil migration (GO:0072677) | 3.04792488 |
| 101 | response to nitrosative stress (GO:0051409) | 3.04474889 |
| 102 | bile acid biosynthetic process (GO:0006699) | 3.03483685 |
| 103 | serine family amino acid catabolic process (GO:0009071) | 3.03327411 |
| 104 | response to muramyl dipeptide (GO:0032495) | 3.02559992 |
| 105 | regulation of fibrinolysis (GO:0051917) | 3.01780760 |
| 106 | germinal center formation (GO:0002467) | 3.01433224 |
| 107 | hemidesmosome assembly (GO:0031581) | 3.01176960 |
| 108 | low-density lipoprotein particle clearance (GO:0034383) | 3.00378093 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99518930 |
| 110 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99518930 |
| 111 | ethanol metabolic process (GO:0006067) | 2.99207831 |
| 112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.98410577 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.97557893 |
| 114 | negative regulation of lipid storage (GO:0010888) | 2.96832889 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 2.96379788 |
| 116 | amine catabolic process (GO:0009310) | 2.96379788 |
| 117 | response to protozoan (GO:0001562) | 2.95701216 |
| 118 | phospholipid homeostasis (GO:0055091) | 2.95370216 |
| 119 | plasma lipoprotein particle clearance (GO:0034381) | 2.93541397 |
| 120 | oligosaccharide catabolic process (GO:0009313) | 2.93143201 |
| 121 | regulation of interleukin-12 production (GO:0032655) | 2.93116136 |
| 122 | cellular response to lipopolysaccharide (GO:0071222) | 2.92969846 |
| 123 | linoleic acid metabolic process (GO:0043651) | 2.92933806 |
| 124 | drug catabolic process (GO:0042737) | 2.92508150 |
| 125 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.92328008 |
| 126 | negative regulation of cholesterol transport (GO:0032375) | 2.90038639 |
| 127 | negative regulation of sterol transport (GO:0032372) | 2.90038639 |
| 128 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.89995067 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89368746 |
| 130 | negative regulation of cell killing (GO:0031342) | 2.89368746 |
| 131 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.88026206 |
| 132 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.87758587 |
| 133 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87238936 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 2.85449803 |
| 135 | positive regulation of p38MAPK cascade (GO:1900745) | 2.85319710 |
| 136 | T cell migration (GO:0072678) | 2.85297644 |
| 137 | regulation of sequestering of triglyceride (GO:0010889) | 2.85140636 |
| 138 | short-chain fatty acid metabolic process (GO:0046459) | 2.84498236 |
| 139 | cholesterol efflux (GO:0033344) | 2.84263635 |
| 140 | regulation of heat generation (GO:0031650) | 2.84072478 |
| 141 | granulocyte activation (GO:0036230) | 2.82806705 |
| 142 | triglyceride homeostasis (GO:0070328) | 2.81532596 |
| 143 | acylglycerol homeostasis (GO:0055090) | 2.81532596 |
| 144 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80866687 |
| 145 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.79853006 |
| 146 | macrophage differentiation (GO:0030225) | 2.79768615 |
| 147 | glycolipid catabolic process (GO:0019377) | 2.79545724 |
| 148 | lymphocyte chemotaxis (GO:0048247) | 2.78999951 |
| 149 | protein-lipid complex remodeling (GO:0034368) | 2.77924037 |
| 150 | macromolecular complex remodeling (GO:0034367) | 2.77924037 |
| 151 | plasma lipoprotein particle remodeling (GO:0034369) | 2.77924037 |
| 152 | cellular modified amino acid catabolic process (GO:0042219) | 2.77508045 |
| 153 | defense response to protozoan (GO:0042832) | 2.77244245 |
| 154 | L-ascorbic acid metabolic process (GO:0019852) | 2.77095832 |
| 155 | regulation of interferon-alpha production (GO:0032647) | 2.76552471 |
| 156 | thioester biosynthetic process (GO:0035384) | 2.74790489 |
| 157 | acyl-CoA biosynthetic process (GO:0071616) | 2.74790489 |
| 158 | negative regulation of interleukin-17 production (GO:0032700) | 2.73789616 |
| 159 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.73114300 |
| 160 | bile acid and bile salt transport (GO:0015721) | 2.72899126 |
| 161 | cellular response to cadmium ion (GO:0071276) | 2.71918727 |
| 162 | regulation of immunoglobulin secretion (GO:0051023) | 2.71717756 |
| 163 | negative regulation of lipase activity (GO:0060192) | 2.71518801 |
| 164 | response to xenobiotic stimulus (GO:0009410) | 2.71482781 |
| 165 | decidualization (GO:0046697) | 2.71282978 |
| 166 | heme biosynthetic process (GO:0006783) | 2.71201697 |
| 167 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70641909 |
| 168 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70469745 |
| 169 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70365886 |
| 170 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.69973213 |
| 171 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69939796 |
| 172 | positive regulation of acute inflammatory response (GO:0002675) | 2.68869353 |
| 173 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.68139554 |
| 174 | response to mercury ion (GO:0046689) | 2.67116624 |
| 175 | regulation of T cell tolerance induction (GO:0002664) | 2.66743234 |
| 176 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66584237 |
| 177 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.66146981 |
| 178 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.66099386 |
| 179 | acute-phase response (GO:0006953) | 2.65453278 |
| 180 | lipoprotein metabolic process (GO:0042157) | 2.65206961 |
| 181 | iron ion import (GO:0097286) | 2.65113644 |
| 182 | phosphate ion transport (GO:0006817) | 2.64981796 |
| 183 | regulation of cholesterol storage (GO:0010885) | 2.64358068 |
| 184 | serine family amino acid metabolic process (GO:0009069) | 2.63706865 |
| 185 | bile acid metabolic process (GO:0008206) | 2.63308875 |
| 186 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.62890887 |
| 187 | fatty acid oxidation (GO:0019395) | 2.60906898 |
| 188 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60379462 |
| 189 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58795123 |
| 190 | regulation of antigen processing and presentation (GO:0002577) | 2.58474557 |
| 191 | positive regulation of interleukin-10 production (GO:0032733) | 2.58404773 |
| 192 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.58350061 |
| 193 | positive regulation of interferon-alpha production (GO:0032727) | 2.57291996 |
| 194 | myeloid cell activation involved in immune response (GO:0002275) | 2.57184608 |
| 195 | positive regulation of B cell differentiation (GO:0045579) | 2.56569761 |
| 196 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56387139 |
| 197 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53627355 |
| 198 | positive regulation of interleukin-12 production (GO:0032735) | 2.53366834 |
| 199 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.53159615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.13328938 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.12092487 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94784429 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.57247540 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.35078038 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 4.09249668 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98734233 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.89482414 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61541755 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.58248311 |
| 11 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 3.44370626 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.37171854 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.33066999 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02169081 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96513554 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.93587742 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.93390337 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.69802613 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62447256 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.61194150 |
| 21 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.55188652 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.55135375 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52166394 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.51290601 |
| 25 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45921813 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42308843 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.21921541 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16165177 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14386894 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13511100 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07058277 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02822590 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02263269 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.02253035 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01787877 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92353483 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90565394 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88859843 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.84954669 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.84687608 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.81932893 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.79443048 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.78402644 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73069764 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72810017 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71653298 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69812667 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67904527 |
| 49 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67723774 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.65885413 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64591969 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63385283 |
| 53 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60720568 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57652903 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57080037 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56449239 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55113055 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.54508820 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53158462 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.52756655 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48125923 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47264185 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46019707 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46005054 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44511752 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44189254 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.43613292 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43090570 |
| 69 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41783658 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40482270 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38794997 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37601438 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35959779 |
| 74 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.33269521 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31761242 |
| 76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31761242 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31662886 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30575779 |
| 79 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30519246 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30227982 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29148151 |
| 82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29120487 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29014578 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28863603 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.28792269 |
| 86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27351803 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26975015 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25972162 |
| 89 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25743121 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24174730 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22859351 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22733107 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21920647 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20581490 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19693316 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19266547 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18924345 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18326674 |
| 99 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17611580 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17221340 |
| 101 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17208088 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14602481 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13756677 |
| 104 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11962118 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11076228 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10876991 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10553303 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09755887 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09628192 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08002881 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07666909 |
| 112 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07235420 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06506316 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06035287 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05991017 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05250277 |
| 117 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04954001 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04716139 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03321294 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01446377 |
| 121 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00046212 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99198369 |
| 123 | MAF_26560356_Chip-Seq_TH2_Human | 0.98756285 |
| 124 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98062562 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97643914 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96413519 |
| 127 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95927416 |
| 128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95777451 |
| 129 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95751508 |
| 130 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95751508 |
| 131 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95742041 |
| 132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95489393 |
| 133 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94969152 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94002206 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93224492 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92211286 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92102286 |
| 138 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91989407 |
| 139 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90825095 |
| 140 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90409424 |
| 141 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90144326 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89518299 |
| 143 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86917084 |
| 144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86070159 |
| 145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85837636 |
| 146 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85139907 |
| 147 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82872046 |
| 148 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82156197 |
| 149 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80954137 |
| 150 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80882033 |
| 151 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80363870 |
| 152 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80039835 |
| 153 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.79818898 |
| 154 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79271577 |
| 155 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78935398 |
| 156 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78288154 |
| 157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78150412 |
| 158 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76983478 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76602706 |
| 160 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76164427 |
| 161 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76164427 |
| 162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.71761782 |
| 163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.70626200 |
| 164 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70612610 |
| 165 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.70260070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.60354396 |
| 2 | MP0005360_urolithiasis | 4.36701795 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.85720941 |
| 4 | MP0005083_abnormal_biliary_tract | 3.56140749 |
| 5 | MP0009785_altered_susceptibility_to | 3.33194465 |
| 6 | MP0004782_abnormal_surfactant_physiolog | 3.27433524 |
| 7 | MP0004147_increased_porphyrin_level | 3.21158119 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.19114222 |
| 9 | MP0005365_abnormal_bile_salt | 3.16631255 |
| 10 | MP0001881_abnormal_mammary_gland | 2.85325987 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.84285435 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.78304124 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.73595249 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.72647949 |
| 15 | MP0006082_CNS_inflammation | 2.69934248 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.64672345 |
| 17 | MP0001790_abnormal_immune_system | 2.55025097 |
| 18 | MP0005387_immune_system_phenotype | 2.55025097 |
| 19 | MP0002419_abnormal_innate_immunity | 2.51352578 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.49212222 |
| 21 | MP0009278_abnormal_bone_marrow | 2.44912939 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.44767761 |
| 23 | MP0005025_abnormal_response_to | 2.42311624 |
| 24 | MP0005671_abnormal_response_to | 2.36585890 |
| 25 | MP0001879_abnormal_lymphatic_vessel | 2.32817559 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 2.29386166 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.28213297 |
| 28 | MP0006054_spinal_hemorrhage | 2.21687881 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.20970623 |
| 30 | MP0001545_abnormal_hematopoietic_system | 2.20970623 |
| 31 | MP0010329_abnormal_lipoprotein_level | 2.20459623 |
| 32 | MP0001853_heart_inflammation | 2.12308971 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.10944450 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 2.10152207 |
| 35 | MP0000685_abnormal_immune_system | 2.07188421 |
| 36 | MP0001958_emphysema | 2.06992652 |
| 37 | MP0002723_abnormal_immune_serum | 2.03265180 |
| 38 | MP0003300_gastrointestinal_ulcer | 2.03115593 |
| 39 | MP0001800_abnormal_humoral_immune | 1.99300784 |
| 40 | MP0003075_altered_response_to | 1.98147354 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.96658365 |
| 42 | MP0002098_abnormal_vibrissa_morphology | 1.91403539 |
| 43 | MP0000604_amyloidosis | 1.87400911 |
| 44 | MP0002405_respiratory_system_inflammati | 1.85546192 |
| 45 | MP0003252_abnormal_bile_duct | 1.80553920 |
| 46 | MP0005332_abnormal_amino_acid | 1.79850736 |
| 47 | MP0002254_reproductive_system_inflammat | 1.79314617 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.77424691 |
| 49 | MP0002796_impaired_skin_barrier | 1.76513516 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.75657723 |
| 51 | MP0001819_abnormal_immune_cell | 1.75604070 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.75126959 |
| 53 | MP0004272_abnormal_basement_membrane | 1.74742630 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.71888497 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.65480958 |
| 56 | MP0003724_increased_susceptibility_to | 1.62120714 |
| 57 | MP0005451_abnormal_body_composition | 1.60083509 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.57777030 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.57403145 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.52381244 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.51664611 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.51413390 |
| 63 | MP0004510_myositis | 1.46540999 |
| 64 | MP0003448_altered_tumor_morphology | 1.45931901 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.45713272 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.41848943 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.41408319 |
| 68 | MP0000609_abnormal_liver_physiology | 1.39764657 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.39132908 |
| 70 | MP0008004_abnormal_stomach_pH | 1.38416569 |
| 71 | MP0005310_abnormal_salivary_gland | 1.35420967 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.34636947 |
| 73 | MP0010678_abnormal_skin_adnexa | 1.33838845 |
| 74 | MP0000716_abnormal_immune_system | 1.33382048 |
| 75 | MP0000858_altered_metastatic_potential | 1.32073853 |
| 76 | MP0005501_abnormal_skin_physiology | 1.26036955 |
| 77 | MP0002398_abnormal_bone_marrow | 1.24429490 |
| 78 | MP0005408_hypopigmentation | 1.22963340 |
| 79 | MP0009840_abnormal_foam_cell | 1.21365587 |
| 80 | MP0009764_decreased_sensitivity_to | 1.20732565 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.17269192 |
| 82 | MP0005647_abnormal_sex_gland | 1.17155085 |
| 83 | MP0002132_abnormal_respiratory_system | 1.13508757 |
| 84 | MP0002429_abnormal_blood_cell | 1.12298987 |
| 85 | MP0001756_abnormal_urination | 1.11204000 |
| 86 | MP0003186_abnormal_redox_activity | 1.10062840 |
| 87 | MP0000689_abnormal_spleen_morphology | 1.09216519 |
| 88 | MP0000627_abnormal_mammary_gland | 1.08619224 |
| 89 | MP0005275_abnormal_skin_tensile | 1.08064062 |
| 90 | MP0000383_abnormal_hair_follicle | 1.07836957 |
| 91 | MP0003690_abnormal_glial_cell | 1.07773069 |
| 92 | MP0002136_abnormal_kidney_physiology | 1.04214750 |
| 93 | MP0002722_abnormal_immune_system | 1.02261254 |
| 94 | MP0001873_stomach_inflammation | 1.01945479 |
| 95 | MP0009763_increased_sensitivity_to | 1.01554300 |
| 96 | MP0001765_abnormal_ion_homeostasis | 1.00770022 |
| 97 | MP0008995_early_reproductive_senescence | 0.99953222 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.99950573 |
| 99 | MP0003828_pulmonary_edema | 0.97396269 |
| 100 | MP0000377_abnormal_hair_follicle | 0.97288899 |
| 101 | MP0000566_synostosis | 0.95519315 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.93534529 |
| 103 | MP0005164_abnormal_response_to | 0.92797543 |
| 104 | MP0001764_abnormal_homeostasis | 0.90444689 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.89457504 |
| 106 | MP0003795_abnormal_bone_structure | 0.89285114 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.89155025 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86733271 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.85602830 |
| 110 | MP0003329_amyloid_beta_deposits | 0.85177251 |
| 111 | MP0002006_tumorigenesis | 0.84280495 |
| 112 | MP0005390_skeleton_phenotype | 0.83936885 |
| 113 | MP0003091_abnormal_cell_migration | 0.81649132 |
| 114 | MP0001542_abnormal_bone_strength | 0.80889530 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.80397257 |
| 116 | MP0000579_abnormal_nail_morphology | 0.79326890 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.77883459 |
| 118 | MP0002060_abnormal_skin_morphology | 0.77474542 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.77460900 |
| 120 | MP0003868_abnormal_feces_composition | 0.77417452 |
| 121 | MP0000598_abnormal_liver_morphology | 0.77168801 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.77086534 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.76456405 |
| 124 | MP0010307_abnormal_tumor_latency | 0.75386675 |
| 125 | MP0004947_skin_inflammation | 0.75375381 |
| 126 | MP0005023_abnormal_wound_healing | 0.74910312 |
| 127 | MP0000465_gastrointestinal_hemorrhage | 0.73912662 |
| 128 | MP0001851_eye_inflammation | 0.73547668 |
| 129 | MP0000537_abnormal_urethra_morphology | 0.73040383 |
| 130 | MP0002133_abnormal_respiratory_system | 0.72190161 |
| 131 | MP0005388_respiratory_system_phenotype | 0.72190161 |
| 132 | MP0004883_abnormal_blood_vessel | 0.71880181 |
| 133 | MP0008469_abnormal_protein_level | 0.71670795 |
| 134 | MP0004130_abnormal_muscle_cell | 0.71545768 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.71425995 |
| 136 | MP0003011_delayed_dark_adaptation | 0.71375266 |
| 137 | MP0003303_peritoneal_inflammation | 0.70746775 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.70365783 |
| 139 | MP0009931_abnormal_skin_appearance | 0.69536337 |
| 140 | MP0000249_abnormal_blood_vessel | 0.68934711 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.68739012 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.67447956 |
| 143 | MP0005166_decreased_susceptibility_to | 0.67259766 |
| 144 | MP0001727_abnormal_embryo_implantation | 0.65614823 |
| 145 | MP0002933_joint_inflammation | 0.65492435 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.65177414 |
| 147 | MP0008260_abnormal_autophagy | 0.64954720 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.64564571 |
| 149 | MP0002135_abnormal_kidney_morphology | 0.64273635 |
| 150 | MP0000647_abnormal_sebaceous_gland | 0.63653845 |
| 151 | MP0002837_dystrophic_cardiac_calcinosis | 0.63384677 |
| 152 | MP0000920_abnormal_myelination | 0.62924040 |
| 153 | MP0005670_abnormal_white_adipose | 0.62853666 |
| 154 | MP0005165_increased_susceptibility_to | 0.62333717 |
| 155 | MP0010155_abnormal_intestine_physiology | 0.61373080 |
| 156 | MP0003195_calcinosis | 0.60904890 |
| 157 | MP0003436_decreased_susceptibility_to | 0.60790067 |
| 158 | MP0009053_abnormal_anal_canal | 0.60291202 |
| 159 | MP0010352_gastrointestinal_tract_polyps | 0.59881043 |
| 160 | MP0000343_altered_response_to | 0.59822642 |
| 161 | MP0000703_abnormal_thymus_morphology | 0.59248061 |
| 162 | MP0010771_integument_phenotype | 0.59215867 |
| 163 | MP0003183_abnormal_peptide_metabolism | 0.57288648 |
| 164 | MP0008874_decreased_physiological_sensi | 0.56959740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.96271314 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.96271314 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.96271314 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.81178969 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.76621178 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.67257713 |
| 7 | Interstitial pulmonary disease (HP:0006530) | 4.53906971 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.51816735 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.49032829 |
| 10 | Onycholysis (HP:0001806) | 4.35312440 |
| 11 | Gout (HP:0001997) | 4.22535043 |
| 12 | Polycythemia (HP:0001901) | 4.04917626 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.97845100 |
| 14 | Complement deficiency (HP:0004431) | 3.84004355 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.81620320 |
| 16 | Abnormality of purine metabolism (HP:0004352) | 3.81337064 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.79114899 |
| 18 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.65738452 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 3.63137075 |
| 20 | Stomatitis (HP:0010280) | 3.57609443 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.56760643 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.56614634 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.56454066 |
| 24 | Tubulointerstitial fibrosis (HP:0005576) | 3.53503842 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49909711 |
| 26 | Loss of speech (HP:0002371) | 3.48433324 |
| 27 | Esophageal varix (HP:0002040) | 3.47638053 |
| 28 | Increased serum ferritin (HP:0003281) | 3.44653341 |
| 29 | Xanthomatosis (HP:0000991) | 3.43858641 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17466043 |
| 31 | Hepatocellular carcinoma (HP:0001402) | 3.16585401 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15670253 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.11305826 |
| 34 | Vascular calcification (HP:0004934) | 3.10475874 |
| 35 | Poikilocytosis (HP:0004447) | 3.09996538 |
| 36 | Hyperglycinuria (HP:0003108) | 3.06813986 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02729027 |
| 38 | T lymphocytopenia (HP:0005403) | 3.00596335 |
| 39 | Disinhibition (HP:0000734) | 2.97754645 |
| 40 | Recurrent viral infections (HP:0004429) | 2.97715582 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.95337363 |
| 42 | Glomerulonephritis (HP:0000099) | 2.94383726 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.92668246 |
| 44 | Recurrent skin infections (HP:0001581) | 2.91229798 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.88093381 |
| 46 | Hematochezia (HP:0002573) | 2.85665510 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84549665 |
| 48 | Acanthocytosis (HP:0001927) | 2.83648925 |
| 49 | Joint hemorrhage (HP:0005261) | 2.82921323 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.82320089 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82290733 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.81443788 |
| 53 | Orchitis (HP:0100796) | 2.78943273 |
| 54 | Abnormality of complement system (HP:0005339) | 2.78126576 |
| 55 | Myositis (HP:0100614) | 2.77577034 |
| 56 | Hyperuricemia (HP:0002149) | 2.74562163 |
| 57 | Increased purine levels (HP:0004368) | 2.74562163 |
| 58 | Epidermoid cyst (HP:0200040) | 2.73218310 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.72866794 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70280856 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70280856 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70280856 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.69841694 |
| 64 | Hyperglycinemia (HP:0002154) | 2.69095057 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.68810344 |
| 66 | Obstructive lung disease (HP:0006536) | 2.68466431 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68466431 |
| 68 | Fat malabsorption (HP:0002630) | 2.65088115 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63636957 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.63636957 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.61950432 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61950432 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.60043144 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.59910791 |
| 75 | Malnutrition (HP:0004395) | 2.59208507 |
| 76 | Increased IgM level (HP:0003496) | 2.57619509 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 2.57236170 |
| 78 | Optic neuritis (HP:0100653) | 2.57236170 |
| 79 | Metaphyseal irregularity (HP:0003025) | 2.56776685 |
| 80 | Renal salt wasting (HP:0000127) | 2.55565082 |
| 81 | Nephritis (HP:0000123) | 2.55398260 |
| 82 | Mutism (HP:0002300) | 2.54688651 |
| 83 | Nausea (HP:0002018) | 2.54364551 |
| 84 | Aortic aneurysm (HP:0004942) | 2.54108058 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 2.53198537 |
| 86 | Reticulocytosis (HP:0001923) | 2.52092394 |
| 87 | Thoracic kyphosis (HP:0002942) | 2.49909799 |
| 88 | Gingivitis (HP:0000230) | 2.48545940 |
| 89 | Amelogenesis imperfecta (HP:0000705) | 2.47720803 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.46671721 |
| 91 | Ketosis (HP:0001946) | 2.41531010 |
| 92 | Petechiae (HP:0000967) | 2.39796756 |
| 93 | Abnormality of chloride homeostasis (HP:0011422) | 2.38730762 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 2.36244960 |
| 95 | Hyperammonemia (HP:0001987) | 2.36127773 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.34749696 |
| 97 | Tachypnea (HP:0002789) | 2.34531172 |
| 98 | Vasculitis (HP:0002633) | 2.33703983 |
| 99 | Respiratory distress (HP:0002098) | 2.32683282 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.32183710 |
| 101 | Woolly hair (HP:0002224) | 2.30204268 |
| 102 | Hemorrhage of the eye (HP:0011885) | 2.29084839 |
| 103 | Spontaneous hematomas (HP:0007420) | 2.28841993 |
| 104 | Hemoptysis (HP:0002105) | 2.28149547 |
| 105 | Hypolipoproteinemia (HP:0010981) | 2.27322422 |
| 106 | Potter facies (HP:0002009) | 2.26199366 |
| 107 | Facial shape deformation (HP:0011334) | 2.26199366 |
| 108 | Spastic diplegia (HP:0001264) | 2.25156308 |
| 109 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24873376 |
| 110 | Pulmonary infiltrates (HP:0002113) | 2.23793761 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.23444496 |
| 112 | Myocardial infarction (HP:0001658) | 2.23124422 |
| 113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22724018 |
| 114 | Amyloidosis (HP:0011034) | 2.22086247 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22035161 |
| 116 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21213720 |
| 117 | Hypoalphalipoproteinemia (HP:0003233) | 2.20018244 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 2.19924268 |
| 119 | Cerebral inclusion bodies (HP:0100314) | 2.19261930 |
| 120 | Combined immunodeficiency (HP:0005387) | 2.16617424 |
| 121 | Abnormality of renal excretion (HP:0011036) | 2.16354159 |
| 122 | Bone pain (HP:0002653) | 2.15958619 |
| 123 | Ileus (HP:0002595) | 2.15835205 |
| 124 | Steatorrhea (HP:0002570) | 2.14952059 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14620577 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14620577 |
| 127 | Premature loss of primary teeth (HP:0006323) | 2.14365174 |
| 128 | Hydroxyprolinuria (HP:0003080) | 2.14122578 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 2.14122578 |
| 130 | Cellulitis (HP:0100658) | 2.12850594 |
| 131 | Tubulointerstitial abnormality (HP:0001969) | 2.11954082 |
| 132 | Cholelithiasis (HP:0001081) | 2.11613813 |
| 133 | Microcytic anemia (HP:0001935) | 2.11048198 |
| 134 | Tetraparesis (HP:0002273) | 2.09758478 |
| 135 | Chronic bronchitis (HP:0004469) | 2.07572126 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 2.07002474 |
| 137 | Hypercholesterolemia (HP:0003124) | 2.06198769 |
| 138 | Meningitis (HP:0001287) | 2.05121775 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 2.04148938 |
| 140 | Purpura (HP:0000979) | 2.04033109 |
| 141 | Osteomyelitis (HP:0002754) | 2.03979116 |
| 142 | Abnormality of the prostate (HP:0008775) | 2.03855126 |
| 143 | Polyneuropathy (HP:0001271) | 2.03841765 |
| 144 | Metabolic acidosis (HP:0001942) | 2.02747628 |
| 145 | Glomerulosclerosis (HP:0000096) | 2.02527825 |
| 146 | Leukocytosis (HP:0001974) | 2.02172243 |
| 147 | Tubulointerstitial nephritis (HP:0001970) | 2.01338284 |
| 148 | Osteolytic defects of the hand bones (HP:0009699) | 2.01176885 |
| 149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01176885 |
| 150 | Diminished motivation (HP:0000745) | 1.99966731 |
| 151 | Rickets (HP:0002748) | 1.99940961 |
| 152 | Conjunctival telangiectasia (HP:0000524) | 1.99558704 |
| 153 | Nonimmune hydrops fetalis (HP:0001790) | 1.99157051 |
| 154 | Abnormality of T cells (HP:0002843) | 1.99017374 |
| 155 | Urticaria (HP:0001025) | 1.97950954 |
| 156 | Keratoconjunctivitis sicca (HP:0001097) | 1.97437696 |
| 157 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97055775 |
| 158 | Systemic lupus erythematosus (HP:0002725) | 1.96600189 |
| 159 | Ketoacidosis (HP:0001993) | 1.96500525 |
| 160 | Aortic dissection (HP:0002647) | 1.96236602 |
| 161 | Widely patent fontanelles and sutures (HP:0004492) | 1.95698189 |
| 162 | Milia (HP:0001056) | 1.95375279 |
| 163 | Colitis (HP:0002583) | 1.95030012 |
| 164 | Joint swelling (HP:0001386) | 1.94777361 |
| 165 | Prostate neoplasm (HP:0100787) | 1.94411760 |
| 166 | Vacuolated lymphocytes (HP:0001922) | 1.93877718 |
| 167 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93820971 |
| 168 | Plantar hyperkeratosis (HP:0007556) | 1.93517455 |
| 169 | Gastrointestinal infarctions (HP:0005244) | 1.93355449 |
| 170 | Abnormal gallbladder morphology (HP:0012437) | 1.93100100 |
| 171 | Congenital, generalized hypertrichosis (HP:0004540) | 1.92487698 |
| 172 | Hypoglycemic seizures (HP:0002173) | 1.90893873 |
| 173 | Pili torti (HP:0003777) | 1.90650576 |
| 174 | Personality changes (HP:0000751) | 1.90370471 |
| 175 | Apathy (HP:0000741) | 1.90321074 |
| 176 | Abnormal cartilage morphology (HP:0002763) | 1.90190940 |
| 177 | Abnormality of the lumbar spine (HP:0100712) | 1.88295663 |
| 178 | Abnormality of B cell number (HP:0010975) | 1.87838375 |
| 179 | Nuclear cataract (HP:0100018) | 1.87721150 |
| 180 | Neuronal loss in central nervous system (HP:0002529) | 1.87301149 |
| 181 | Recurrent bronchitis (HP:0002837) | 1.86389818 |
| 182 | Keratoconjunctivitis (HP:0001096) | 1.86175476 |
| 183 | Amaurosis fugax (HP:0100576) | 1.85745545 |
| 184 | Pustule (HP:0200039) | 1.85348661 |
| 185 | Abnormality of the periventricular white matter (HP:0002518) | 1.84731735 |
| 186 | Progressive visual loss (HP:0000529) | 1.84411136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.30494922 |
| 2 | KDR | 3.75372153 |
| 3 | TGFBR2 | 3.49969060 |
| 4 | ERN1 | 3.22393412 |
| 5 | SIK1 | 3.03136205 |
| 6 | MATK | 2.91496278 |
| 7 | LATS1 | 2.57527111 |
| 8 | BCKDK | 2.47610786 |
| 9 | TXK | 2.43123295 |
| 10 | MST4 | 2.39892480 |
| 11 | PRPF4B | 2.37762585 |
| 12 | FRK | 2.31333273 |
| 13 | GRK7 | 2.28640028 |
| 14 | TAOK2 | 2.15832901 |
| 15 | IKBKB | 2.12839155 |
| 16 | DDR2 | 2.12383536 |
| 17 | RIPK4 | 2.11847470 |
| 18 | LRRK2 | 2.07900573 |
| 19 | BLK | 2.04461688 |
| 20 | EEF2K | 2.03656389 |
| 21 | MAP4K1 | 2.01082127 |
| 22 | PKN2 | 2.00438372 |
| 23 | MAP3K3 | 1.90853317 |
| 24 | FGFR4 | 1.90221007 |
| 25 | MYLK | 1.86461690 |
| 26 | MAP3K13 | 1.84563367 |
| 27 | PTK6 | 1.84050194 |
| 28 | TRIB3 | 1.75866813 |
| 29 | EPHB2 | 1.75742664 |
| 30 | IRAK4 | 1.73607482 |
| 31 | TAOK3 | 1.73024290 |
| 32 | MAPKAPK3 | 1.72142558 |
| 33 | STK10 | 1.71246963 |
| 34 | RIPK1 | 1.68983179 |
| 35 | MST1R | 1.67126451 |
| 36 | GRK1 | 1.66752595 |
| 37 | PIM2 | 1.58412096 |
| 38 | EPHA2 | 1.55623597 |
| 39 | CAMK1D | 1.55028294 |
| 40 | NUAK1 | 1.47957020 |
| 41 | NEK9 | 1.43653814 |
| 42 | FGR | 1.43358698 |
| 43 | ACVR1B | 1.41523206 |
| 44 | FGFR2 | 1.40317022 |
| 45 | BMPR2 | 1.37544986 |
| 46 | ZAP70 | 1.33610454 |
| 47 | PDK2 | 1.27368289 |
| 48 | TGFBR1 | 1.21930791 |
| 49 | FER | 1.19689653 |
| 50 | HIPK2 | 1.18609772 |
| 51 | CHUK | 1.13831264 |
| 52 | TYK2 | 1.07757676 |
| 53 | MAP2K3 | 1.07648425 |
| 54 | CDK6 | 1.07554500 |
| 55 | PIK3CG | 1.07134883 |
| 56 | CDC42BPA | 1.06186650 |
| 57 | EPHB1 | 1.05484735 |
| 58 | LYN | 1.03782083 |
| 59 | PDK3 | 1.01396404 |
| 60 | PDK4 | 1.01396404 |
| 61 | INSRR | 1.00039192 |
| 62 | STK3 | 0.98161438 |
| 63 | MOS | 0.93976440 |
| 64 | CSF1R | 0.93374984 |
| 65 | CAMK1G | 0.92942408 |
| 66 | MAP3K1 | 0.92644934 |
| 67 | KIT | 0.92550121 |
| 68 | PRKAA2 | 0.92357496 |
| 69 | TBK1 | 0.92083473 |
| 70 | STK38L | 0.91500301 |
| 71 | JAK2 | 0.89173905 |
| 72 | SYK | 0.87782199 |
| 73 | PDGFRB | 0.87255227 |
| 74 | STK24 | 0.83407689 |
| 75 | WNK4 | 0.83255137 |
| 76 | IRAK1 | 0.82991493 |
| 77 | MAP3K2 | 0.82755724 |
| 78 | PAK4 | 0.81916329 |
| 79 | ADRBK2 | 0.80594808 |
| 80 | TRPM7 | 0.80257926 |
| 81 | MAP2K2 | 0.79716744 |
| 82 | STK39 | 0.78277801 |
| 83 | CLK1 | 0.77096005 |
| 84 | TAOK1 | 0.76613487 |
| 85 | SMG1 | 0.75943197 |
| 86 | JAK3 | 0.74474134 |
| 87 | RPS6KB2 | 0.73357321 |
| 88 | LCK | 0.73154401 |
| 89 | PIM1 | 0.72870205 |
| 90 | EPHA3 | 0.72558582 |
| 91 | GSK3A | 0.72456740 |
| 92 | BTK | 0.71652384 |
| 93 | MAPK11 | 0.69911880 |
| 94 | PRKG2 | 0.69399874 |
| 95 | PBK | 0.68412253 |
| 96 | LMTK2 | 0.67857331 |
| 97 | SCYL2 | 0.66363993 |
| 98 | MET | 0.64977212 |
| 99 | PTK2 | 0.64643859 |
| 100 | FLT3 | 0.64440010 |
| 101 | FGFR3 | 0.64154477 |
| 102 | DAPK2 | 0.62665475 |
| 103 | HCK | 0.62424282 |
| 104 | PIK3CA | 0.62263656 |
| 105 | JAK1 | 0.61468432 |
| 106 | TESK2 | 0.61244441 |
| 107 | IRAK2 | 0.60824568 |
| 108 | IRAK3 | 0.60665638 |
| 109 | MAP3K14 | 0.60449280 |
| 110 | EIF2AK3 | 0.59628631 |
| 111 | PDGFRA | 0.59512913 |
| 112 | RPS6KL1 | 0.58412141 |
| 113 | RPS6KC1 | 0.58412141 |
| 114 | MAPK15 | 0.57747204 |
| 115 | AKT3 | 0.57489982 |
| 116 | MAP3K7 | 0.57414422 |
| 117 | LATS2 | 0.54897913 |
| 118 | EGFR | 0.54300225 |
| 119 | NME2 | 0.52919853 |
| 120 | RPS6KA4 | 0.52630155 |
| 121 | CDK4 | 0.52429280 |
| 122 | DYRK1B | 0.52359323 |
| 123 | MAP3K5 | 0.52208227 |
| 124 | CSK | 0.51395346 |
| 125 | DAPK1 | 0.50120993 |
| 126 | PAK2 | 0.49768339 |
| 127 | ARAF | 0.48812497 |
| 128 | MAPK12 | 0.48090217 |
| 129 | IGF1R | 0.47443408 |
| 130 | FES | 0.47154366 |
| 131 | PTK2B | 0.46958522 |
| 132 | EIF2AK1 | 0.45033872 |
| 133 | MAP2K1 | 0.44808438 |
| 134 | DAPK3 | 0.44213544 |
| 135 | MAPK4 | 0.44031003 |
| 136 | OXSR1 | 0.43882922 |
| 137 | RAF1 | 0.42762580 |
| 138 | MARK3 | 0.42732071 |
| 139 | RPS6KA6 | 0.42249818 |
| 140 | ERBB2 | 0.42048153 |
| 141 | KSR2 | 0.41990358 |
| 142 | IKBKE | 0.40962300 |
| 143 | NLK | 0.40744083 |
| 144 | CAMKK2 | 0.40494438 |
| 145 | TEC | 0.39592255 |
| 146 | EIF2AK2 | 0.39506317 |
| 147 | ABL1 | 0.37873932 |
| 148 | MAP3K8 | 0.37706809 |
| 149 | TTN | 0.35950431 |
| 150 | ALK | 0.34533937 |
| 151 | BMX | 0.33595774 |
| 152 | ITK | 0.33309347 |
| 153 | RPS6KA2 | 0.32767710 |
| 154 | ABL2 | 0.32305736 |
| 155 | PDK1 | 0.31555781 |
| 156 | MAP3K11 | 0.31234140 |
| 157 | BRAF | 0.30803482 |
| 158 | PDPK1 | 0.30168445 |
| 159 | MAPK7 | 0.30019097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.14292213 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.28484757 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.96294439 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.94974954 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82040410 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73162291 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54570836 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52812962 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.50832503 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45065825 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42485393 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38491640 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.33644385 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.32429364 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31277815 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.30481265 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29737075 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.23952221 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23589156 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22434328 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16053995 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14338187 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11807306 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08277720 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07835028 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.04299079 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02956414 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.97137401 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90407627 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89035356 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.88302029 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86848367 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86578167 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.83592771 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81573620 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78496433 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77253205 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.77064822 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.76281058 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76151241 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72419853 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72088382 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66591027 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.65809081 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61478720 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60069087 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59893178 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59263054 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58291052 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.57538730 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57518411 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.55685632 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53614466 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.47258175 |
| 55 | Measles_Homo sapiens_hsa05162 | 1.45640904 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44418939 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.43317355 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42824532 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42562068 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42011007 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41988392 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39862366 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38072363 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33529132 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 1.28952545 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25376231 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24792393 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20648223 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18243770 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 1.17026933 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 1.15285403 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14738397 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12354647 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10667773 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10572426 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10538380 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08855141 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08823447 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 1.07986951 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05229436 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05225560 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02572625 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01488982 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.97112813 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96518104 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95173643 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93804540 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91155883 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91012910 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90271564 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87796436 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86514781 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85608280 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82737722 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81232321 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81097479 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80924329 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.80867247 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79135572 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71345330 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68856260 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67346912 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64741449 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64377043 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63456548 |
| 106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63205155 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62664231 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62145942 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61380573 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61306257 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60907737 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60061611 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58150148 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57045643 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56897298 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56742146 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56720140 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55376851 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55107392 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54840667 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54593329 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53771064 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53187998 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51265655 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.51044313 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.50821570 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49668743 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.49399394 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48878496 |
| 130 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48643161 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48375033 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47340557 |
| 133 | Lysosome_Homo sapiens_hsa04142 | 0.47073600 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.46283094 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45975168 |
| 136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45675868 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.45045989 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.41228638 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39433803 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38839315 |
| 141 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38549843 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.38062917 |
| 143 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37652078 |
| 144 | Focal adhesion_Homo sapiens_hsa04510 | 0.34725861 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34365585 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33160927 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32815125 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32651426 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31294876 |
| 150 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30346823 |
| 151 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28191370 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28146580 |
| 153 | Pertussis_Homo sapiens_hsa05133 | 0.27293643 |
| 154 | Tight junction_Homo sapiens_hsa04530 | 0.27081972 |
| 155 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25383499 |
| 156 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25261707 |
| 157 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24600002 |
| 158 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23502375 |
| 159 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21271219 |
| 160 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19511228 |
| 161 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19408219 |
| 162 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18575458 |
| 163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17980671 |
| 164 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17211769 |
| 165 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.16913206 |
| 166 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15415207 |
| 167 | Legionellosis_Homo sapiens_hsa05134 | 0.15091235 |
| 168 | Endocytosis_Homo sapiens_hsa04144 | 0.10478603 |
| 169 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09740426 |
| 170 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08054119 |

